As of 2026-03-23, the Relative Valuation of Stoke Therapeutics Inc (STOK) is 18.59 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.51 USD, the upside of Stoke Therapeutics Inc based on Relative Valuation is -44.5%.
The range of the Relative Valuation is 15.47 - 21.95 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.4x - 30.5x | 26.8x |
| Forward P/E multiples | 21.5x - 30.4x | 25.0x |
| Fair Price | 15.47 - 21.95 | 18.59 |
| Upside | -53.8% - -34.5% | -44.5% |
| Date | P/E |
| 2026-03-13 | 46.18 |
| 2026-03-12 | 50.76 |
| 2026-03-11 | 52.79 |
| 2026-03-10 | 53.36 |
| 2026-03-09 | 53.31 |
| 2026-03-06 | 49.37 |
| 2026-03-05 | 48.22 |
| 2026-03-04 | 47.90 |
| 2026-03-03 | 47.01 |
| 2026-03-02 | 51.05 |
| 2026-02-27 | 50.66 |
| 2026-02-26 | 49.47 |
| 2026-02-25 | 49.40 |
| 2026-02-24 | 49.40 |
| 2026-02-23 | 50.41 |
| 2026-02-20 | 47.71 |
| 2026-02-19 | 47.83 |
| 2026-02-18 | 43.11 |
| 2026-02-17 | 43.26 |
| 2026-02-13 | 44.40 |
| 2026-02-12 | 44.38 |
| 2026-02-11 | 44.83 |
| 2026-02-10 | 45.14 |
| 2026-02-09 | 44.51 |
| 2026-02-06 | 45.08 |
| 2026-02-05 | 42.41 |
| 2026-02-04 | 44.53 |
| 2026-02-03 | 47.02 |
| 2026-02-02 | 42.82 |
| 2026-01-30 | 42.22 |
| 2026-01-29 | 43.23 |
| 2026-01-28 | 40.91 |
| 2026-01-27 | 41.06 |
| 2026-01-26 | 40.70 |
| 2026-01-23 | 40.99 |
| 2026-01-22 | 41.81 |
| 2026-01-21 | 41.05 |
| 2026-01-20 | 39.96 |
| 2026-01-16 | 39.94 |
| 2026-01-15 | 40.74 |
| 2026-01-14 | 43.09 |
| 2026-01-13 | 42.55 |
| 2026-01-12 | 40.94 |
| 2026-01-09 | 45.71 |
| 2026-01-08 | 46.87 |
| 2026-01-07 | 48.94 |
| 2026-01-06 | 49.01 |
| 2026-01-05 | 45.29 |
| 2026-01-02 | 43.00 |
| 2025-12-31 | 44.17 |